Chemed
CHE
#2705
Rank
C$8.62 B
Marketcap
C$592.00
Share price
-1.52%
Change (1 day)
-25.88%
Change (1 year)
Chemed Corporation is an American company that provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

P/E ratio for Chemed (CHE)

P/E ratio as of December 2025 (TTM): 22.3

According to Chemed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.273. At the end of 2024 the company had a P/E ratio of 26.2.

P/E ratio history for Chemed from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202426.2-18.28%
202332.16.19%
202230.2-0.67%
202130.516.29%
202026.2-16.47%
201931.444.73%
201821.7-44.14%
201738.865.78%
201623.46.1%
201522.026.38%
201417.42.37%
201317.025.6%
201213.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Amedisys
AMED
38.7 73.72%๐Ÿ‡บ๐Ÿ‡ธ USA
LHC Group
LHCG
82.4 270.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Sensient Technologies
SXT
28.7 28.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Balchem
BCPC
33.4 49.92%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.